Axoft’s bioinspired, scalable implant promotes long-term communication with the nervous system — transforming clinical outcomes, individual health, and the human experience.
Lab-to-Launch Lounge
Thursday, March 21, 2024
Tianyang Ye is the CTO and co-founder of Axoft, a company that provides bio-inspired implantable devices to promote long-term communication with the nervous system. Ye holds a Ph.D. in Mechanical Engineering from Harvard University and was previously a Fellow at Harvard’s Office of Technology Development, where he translated academic research from Harvard labs into industry application and strategized commercialization roadmaps for research lab innovations. Ye’s research at Harvard focused on bioelectronics, a field at the intersection of nanotechnology and bio-engineering. His work has helped the team perfect their sensors’ reactivity to the electrical signals emitted from our cells. Axoft’s flagship product is a scalable implant that can be used to treat long-term neurological disorders. The company recently raised $8 million in seed funding to expand its product offerings and accelerate growth
One piece of advice to Venturing@Harvard
"For the one piece of advice from lecturers in the series, mine will be " You cannot achieve greatness alone. Make friends before you need them. Getting to know one more person in the long run is much more rewarding than reading one more paper or doing one more experiment."
